Is combination treatment with meropenem plus levofloxacin synergistic against Pseudomonas aeruginosa infection in a murine model of pneumonia?
The combination of meropenem plus levofloxacin was synergistic, producing good bacterial kill and resistance suppression. Given the track record of safety of each agent, this combination may be worthy of clinical trial.
We demonstrated differential PKCalpha expression in RCC tissues, indicating that abnormal PKCalpha activation may contribute to the development of RCC.